Diagnostic Imaging spoke with Radiology Partners Chairman and CEO Rich Whitney, Associate CMO Nina Kottler, M.D., and MEDNAX Radiology Solutions CMO Ricardo Cury, M.D., about this newly finalized partnership, what it means for the companies, and how it could impact the industry.
On Dec. 16, Radiology Partners and MEDNAX Radiology Solutions announced the completion of their partnership – a deal that has been valued at $885 million.
This agreement fuses MEDNAX’s more than 800 radiologists with the 1,600 providers who currently work for Radiology Partners. More than 300 of MEDNAX’s providers currently work onsite in several states, and 500 more are teleradiologists.
Across the industry, this partnership is expected to open doors for larger clinical programs and significant levels of innovation. Diagnostic Imaging sat down with MEDNAX chief medical officer Ricardo Cury, M.D., as well as Radiology Partners chairman and chief executive officer Rich Whitney and associate chief medical officer Nina Kottler, M.D., to talk about why this merger is a good fit, what new capabilities it introduces, and what it could mean for radiology as a whole.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.